Clinical trial
The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy
NCT05525156 is registered in ClinicalTrials.gov with Muhimbili University of Health and Allied Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy
- Lead sponsor
- Muhimbili University of Health and Allied Sciences
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- March 2, 2020
- Completion date
- June 22, 2023
- Enrollment
- 454 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.